FR19C1030I1 - DRUG DELIVERY SYSTEM FOR DELIVERING POORLY WATER SOLUBLE PHARMACEUTICALLY ACTIVE SUBSTANCES - Google Patents

DRUG DELIVERY SYSTEM FOR DELIVERING POORLY WATER SOLUBLE PHARMACEUTICALLY ACTIVE SUBSTANCES

Info

Publication number: FR19C1030I1
Authority: FR; France
Prior art keywords: delivery system; drug delivery; water soluble; active substances; pharmaceutically active
Prior art date: 2007-12-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR19C1030C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ardenia Investments Ltd

Original Assignee

Ardenia Investments Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-19

Filing date

2019-05-06

Publication date

2019-06-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40795732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR19C1030(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-05-06 Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd

2019-06-21 Publication of FR19C1030I1 publication Critical patent/FR19C1030I1/en

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Physics & Mathematics (AREA)
Biomedical Technology (AREA)
Nanotechnology (AREA)
Optics & Photonics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Transplantation (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FR19C1030C 2007-12-19 2019-05-06 DRUG DELIVERY SYSTEM FOR DELIVERING POORLY WATER SOLUBLE PHARMACEUTICALLY ACTIVE SUBSTANCES Active FR19C1030I1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/SE2007/001127 WO2009078754A1 (en)	2007-12-19	2007-12-19	Drug delivery system for administration of poorly water soluble pharmaceutically active substances
PCT/SE2008/051515 WO2009078802A1 (en)	2007-12-19	2008-12-18	Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Publications (1)

Publication Number	Publication Date
FR19C1030I1 true FR19C1030I1 (en)	2019-06-21

Family

ID=40795732

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR19C1030C Active FR19C1030I1 (en)	2007-12-19	2019-05-06	DRUG DELIVERY SYSTEM FOR DELIVERING POORLY WATER SOLUBLE PHARMACEUTICALLY ACTIVE SUBSTANCES

Country Status (27)

Country	Link
US (4)	US8999382B2 (en)
EP (1)	EP2231189B1 (en)
JP (1)	JP5466172B2 (en)
KR (1)	KR101572703B1 (en)
CN (1)	CN101951956B (en)
AU (1)	AU2008339099B2 (en)
BR (1)	BRPI0821740B1 (en)
CA (1)	CA2709266C (en)
CY (2)	CY1119805T1 (en)
DK (1)	DK2231189T3 (en)
EA (1)	EA015247B1 (en)
ES (1)	ES2650242T3 (en)
FR (1)	FR19C1030I1 (en)
HR (1)	HRP20171796T1 (en)
HU (1)	HUE034684T2 (en)
LT (2)	LT2231189T (en)
LU (1)	LUC00117I2 (en)
MX (1)	MX2010006914A (en)
MY (2)	MY157186A (en)
NL (1)	NL300987I9 (en)
NO (2)	NO2231189T3 (en)
NZ (1)	NZ586859A (en)
PL (1)	PL2231189T3 (en)
PT (1)	PT2231189T (en)
SI (1)	SI2231189T1 (en)
WO (2)	WO2009078754A1 (en)
ZA (1)	ZA201004685B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009078755A1 (en)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078756A1 (en)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) *	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of poorly water soluble pharmaceutically active substances
US20110223201A1 (en) *	2009-04-21	2011-09-15	Selecta Biosciences, Inc.	Immunonanotherapeutics Providing a Th1-Biased Response
CN102905729A (en)	2010-05-26	2013-01-30	西莱克塔生物科技公司	Dose selection of adjuvanted synthetic nanocarriers
US9994443B2 (en)	2010-11-05	2018-06-12	Selecta Biosciences, Inc.	Modified nicotinic compounds and related methods
CN103908432B (en) *	2013-01-02	2018-09-21	博瑞生物医药（苏州）股份有限公司	A kind of freeze-dried composition and preparation method thereof of Ipsapirone albumin
CN112321465B (en) *	2019-07-18	2023-06-06	上海现代药物制剂工程研究中心有限公司	A phenyl-containing compound, its intermediate, preparation method and application
CN112239418B (en) *	2019-07-18	2023-07-07	上海现代药物制剂工程研究中心有限公司	Preparation method of retinol compound and sodium salt thereof
WO2021259472A1 (en) *	2020-06-24	2021-12-30	Oasmia Pharmaceutical Ab	Micellar docetaxel for use in the treatment of cancer
CN115429886A (en) *	2021-06-02	2022-12-06	复旦大学	A kind of drug nano crystal preparation and preparation method thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6096331A (en) *	1993-02-22	2000-08-01	Vivorx Pharmaceuticals, Inc.	Methods and compositions useful for administration of chemotherapeutic agents
DE19839566C2 (en) *	1998-08-31	2002-01-17	Fumapharm Ag Muri	Use of fumaric acid derivatives in transplant medicine
US6197809B1 (en) *	1998-12-23	2001-03-06	Ardenia Investments Ltd.	Compounds for the treatment of cancer
US6656504B1 (en)	1999-09-09	2003-12-02	Elan Pharma International Ltd.	Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
SE0101702D0 (en) *	2001-05-15	2001-05-15	Ardenia Investments Ltd	Novel potentiating compounds
US20050249786A1 (en) *	2001-09-28	2005-11-10	Solubest Ltd.	Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
US20050191359A1 (en) *	2001-09-28	2005-09-01	Solubest Ltd.	Water soluble nanoparticles and method for their production
EP1534672B1 (en) *	2002-07-23	2013-05-01	Ardenia Investments Ltd.	Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents
SE0202311D0 (en) *	2002-07-23	2002-07-23	Ardenia Investments Ltd	Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment
US7259984B2 (en) *	2002-11-26	2007-08-21	Cornell Research Foundation, Inc.	Multibit metal nanocrystal memories and fabrication
JP2006199590A (en)	2003-09-04	2006-08-03	Nano Career Kk	Composition containing nanoparticle containing water-soluble basic medicine encapsulated therein
WO2005089106A2 (en)	2004-02-27	2005-09-29	Molecular Therapeutics, Inc.	Degradable nanoparticles
US7871632B2 (en)	2004-07-12	2011-01-18	Adventrx Pharmaceuticals, Inc.	Compositions for delivering highly water soluble drugs
US8945629B2 (en) *	2004-09-10	2015-02-03	University Of Wyoming	Nanoparticles for cytoplasmic drug delivery to cancer cells
KR101457834B1 (en) *	2005-08-31	2014-11-05	아브락시스 바이오사이언스, 엘엘씨	Compositions and methods for preparation of poorly water soluble drugs with increased stability
WO2009078754A1 (en)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of poorly water soluble pharmaceutically active substances
WO2009078756A1 (en) *	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078755A1 (en) *	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance

2007
- 2007-12-19 WO PCT/SE2007/001127 patent/WO2009078754A1/en active Application Filing
2008
- 2008-12-18 MY MYPI2010002787A patent/MY157186A/en unknown
- 2008-12-18 US US12/809,252 patent/US8999382B2/en active Active
- 2008-12-18 SI SI200831891T patent/SI2231189T1/en unknown
- 2008-12-18 AU AU2008339099A patent/AU2008339099B2/en active Active
- 2008-12-18 DK DK08861526.5T patent/DK2231189T3/en active
- 2008-12-18 JP JP2010539385A patent/JP5466172B2/en active Active
- 2008-12-18 WO PCT/SE2008/051515 patent/WO2009078802A1/en active Application Filing
- 2008-12-18 EP EP08861526.5A patent/EP2231189B1/en active Active
- 2008-12-18 ES ES08861526.5T patent/ES2650242T3/en active Active
- 2008-12-18 CN CN2008801270180A patent/CN101951956B/en active Active
- 2008-12-18 NO NO08861526A patent/NO2231189T3/no unknown
- 2008-12-18 EA EA200802350A patent/EA015247B1/en unknown
- 2008-12-18 LT LTEP08861526.5T patent/LT2231189T/en unknown
- 2008-12-18 HU HUE08861526A patent/HUE034684T2/en unknown
- 2008-12-18 PL PL08861526T patent/PL2231189T3/en unknown
- 2008-12-18 PT PT88615265T patent/PT2231189T/en unknown
- 2008-12-18 NZ NZ586859A patent/NZ586859A/en unknown
- 2008-12-18 CA CA2709266A patent/CA2709266C/en active Active
- 2008-12-18 BR BRPI0821740-8A patent/BRPI0821740B1/en active IP Right Grant
- 2008-12-18 MY MYPI2010002786A patent/MY157187A/en unknown
- 2008-12-18 MX MX2010006914A patent/MX2010006914A/en active IP Right Grant
- 2008-12-18 KR KR1020107015610A patent/KR101572703B1/en active Active
2010
- 2010-07-02 ZA ZA2010/04685A patent/ZA201004685B/en unknown
2015
- 2015-02-27 US US14/633,177 patent/US9993438B2/en not_active Ceased
2017
- 2017-11-20 HR HRP20171796TT patent/HRP20171796T1/en unknown
- 2017-12-04 CY CY20171101264T patent/CY1119805T1/en unknown
2019
- 2019-04-24 CY CY2019021C patent/CY2019021I1/en unknown
- 2019-04-25 LT LTPA2019508C patent/LTPA2019508I1/en unknown
- 2019-05-03 LU LU00117C patent/LUC00117I2/fr unknown
- 2019-05-06 NL NL300987C patent/NL300987I9/en unknown
- 2019-05-06 FR FR19C1030C patent/FR19C1030I1/en active Active
- 2019-05-08 NO NO2019023C patent/NO2019023I1/en unknown
2020
- 2020-06-12 US US16/899,848 patent/USRE49741E1/en active Active
2021
- 2021-02-17 US US17/177,550 patent/USRE49742E1/en active Active

Also Published As

Publication number	Publication date
US20150164819A1 (en)	2015-06-18
CY2019021I2 (en)	2019-11-27
US9993438B2 (en)	2018-06-12
JP5466172B2 (en)	2014-04-09
SI2231189T1 (en)	2018-03-30
NO2019023I1 (en)	2019-05-08
KR101572703B1 (en)	2015-11-27
EA200802350A2 (en)	2009-06-30
JP2011507838A (en)	2011-03-10
DK2231189T3 (en)	2017-12-11
USRE49742E1 (en)	2023-12-05
EA015247B1 (en)	2011-06-30
WO2009078802A1 (en)	2009-06-25
NL300987I9 (en)	2019-05-16
KR20100094575A (en)	2010-08-26
LT2231189T (en)	2017-12-27
EA200802350A3 (en)	2009-10-30
NO2231189T3 (en)	2018-02-03
CN101951956B (en)	2012-10-17
ZA201004685B (en)	2011-03-30
HRP20171796T1 (en)	2018-01-26
AU2008339099A1 (en)	2009-06-25
HUE034684T2 (en)	2018-02-28
LUC00117I2 (en)	2024-05-22
US8999382B2 (en)	2015-04-07
CY1119805T1 (en)	2018-06-27
PT2231189T (en)	2017-12-12
ES2650242T3 (en)	2018-01-17
EP2231189A4 (en)	2013-10-09
BRPI0821740B1 (en)	2021-05-18
EP2231189A1 (en)	2010-09-29
EP2231189B1 (en)	2017-09-06
USRE49741E1 (en)	2023-12-05
NL300987I2 (en)	2019-05-09
NZ586859A (en)	2012-06-29
MY157187A (en)	2016-05-13
MX2010006914A (en)	2010-11-10
LTPA2019508I1 (en)	2019-05-10
CA2709266A1 (en)	2009-06-25
PL2231189T3 (en)	2018-03-30
CN101951956A (en)	2011-01-19
CY2019021I1 (en)	2019-11-27
MY157186A (en)	2016-05-13
WO2009078754A1 (en)	2009-06-25
CA2709266C (en)	2017-09-26
US20110014281A1 (en)	2011-01-20
BRPI0821740A2 (en)	2020-02-27
AU2008339099B2 (en)	2015-08-13

Publication	Publication Date	Title
FR19C1030I1 (en)	2019-06-21	DRUG DELIVERY SYSTEM FOR DELIVERING POORLY WATER SOLUBLE PHARMACEUTICALLY ACTIVE SUBSTANCES
EP1909772A4 (en)	2011-07-13	FORMULATION FOR TRANSDERMAL DRUG DELIVERY
FR17C1027I2 (en)	2020-09-04	USEFUL LIPOSOMES FOR DRUG DELIVERY
EP2571526A4 (en)	2014-06-25	DRUG DELIVERY DEVICES FOR ADMINISTERING OCULAR THERAPEUTIC AGENTS
EP2056903A4 (en)	2012-07-25	TOURBILLONARY ELEMENT FOR DRUG DELIVERY SYSTEM
EP1807018A4 (en)	2012-07-04	IN SITU DELIVERY SYSTEM OF CONTROLLED RELEASE DRUGS
EP2361647A4 (en)	2015-08-19	DEVICE FOR DELIVERY OF MEDICAMENT
WO2009088414A3 (en)	2009-12-30	Oral pharmaceutical dosage forms
EP2514387A4 (en)	2013-05-29	ULTRASONIC DRUG DELIVERY SYSTEM AND METHOD FOR DENTAL USE
EP2182799A4 (en)	2015-01-21	SUPRAMOLECULAR FUNCTIONALIZATION OF GRAPHIC NANOPARTICLES FOR DRUG DELIVERY
EP1807146A4 (en)	2013-07-03	COMPOSITION FOR IMPROVING THE EFFICACY OF DRUG DELIVERY
EP2035488A4 (en)	2010-06-16	MICELLES FOR DRUG DELIVERY
IL202614A0 (en)	2010-06-30	Intravaginal drug delivery devices for the delivery of macromolecules and water soluble drugs
EP2099434A4 (en)	2014-07-23	DEVICES, SYSTEMS AND METHODS FOR DRUG DELIVERY
EP2516671A4 (en)	2015-08-05	SYSTEMS FOR MANAGING DRUG DELIVERY DEVICES
EP2056792A4 (en)	2013-04-24	DRUG DELIVERY SYSTEMS COMPRISING SOLID SOLUTIONS OF LOW BASIC MEDICINES
EP2385827A4 (en)	2012-06-27	SYSTEM FOR DELIVERING PHARMACEUTICAL DOSES
EP2219725A4 (en)	2011-05-18	DRUG DELIVERY SLEEVE
IL196394A0 (en)	2009-09-22	Implantable sustained drug delivery device for releasing active agents to the osteomeatal complex
EP2515968A4 (en)	2014-09-03	NASAL MONODOSE DRUG DELIVERY DEVICE
EP2023900A4 (en)	2012-12-26	Controlled dose drug delivery system
ZA200610770B (en)	2008-08-27	Dosage form for delivery of multiple drug forms
EP1983930A4 (en)	2012-12-26	Drug delivery system for retarding release of water soluble drugs
EP2488207A4 (en)	2015-06-10	POLYMERIC SYSTEMS FOR ADMINISTERING ANTICANCER AGENTS
HRP20181517T1 (en)	2018-11-30	Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance